InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.22
(
0.35%
)
Bitcoin
57,822.81
(
-3.89%
)
Post# of 252484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: DewDiligence post# 4104

Thursday, 10/14/2004 10:54:32 AM

Thursday, October 14, 2004 10:54:32 AM

Post# of 252484
I don't consider the Retaane trial to be a failure in the clinical sense. We have no idea whether or not the patients who respond to Retaane versus Visudyne are overlapping populations, or entirely exclusive populations. We just do not design clinical trials to test this scenario... and I wonder if we're therefore throwing away drugs with utility.

I will agree that this is a failure for the stock.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up